Equifax CEO Mark Begor Executes Substantial Stock Sale and Receives Option Grant in Mid-July Transaction

CEO Executes Pre-Planned Equity Sales Totaling Approximately 37,791 Shares

Mark W. Begor, who serves as Chief Executive Officer and Director of Equifax Inc., sold a combined total of approximately 37,791 common shares on July 24, 2026. The filing disclosure indicates that these sales were executed in multiple transactions throughout the trading day, with share prices varying across each block of sales. The transactions were effected pursuant to a Rule 10b5-1 trading plan that Begor adopted on October 28, 2025, which provides an affirmative defense against insider trading allegations when trades are executed according to pre-established parameters.

The sales occurred across ten separate transaction codes, each involving different quantities of shares at weighted average prices. The lowest weighted average price reported was $168.47 per share, while the highest was $175.85 per share. According to the filing, the actual prices at which individual shares were sold ranged from as low as $168.40 to as high as $175.94. The use of weighted average pricing for reporting reflects the execution of sales at multiple price points throughout the trading session, a common occurrence when large blocks of stock are liquidated over the course of a single day.

Trading Plan Adoption and Regulatory Compliance Framework

The disclosure filing notes that all share sales reported in the Form 4 were effected pursuant to the Rule 10b5-1 trading plan that Begor established on October 28, 2025. Rule 10b5-1 plans allow corporate insiders to execute pre-arranged trades during periods when they would otherwise be restricted from trading due to their access to material nonpublic information. By adopting such a plan well in advance of the actual trading execution, insiders can demonstrate that their trades were not motivated by knowledge of undisclosed corporate developments.

This regulatory framework is designed to protect both the company and its executives by reducing the appearance of impropriety in insider trading activity. The fact that Begor's October 2025 adoption date predated the July 2026 trading activity by approximately nine months suggests a deliberate planning horizon for equity management. The filing does not disclose the specific terms or conditions of the trading plan beyond the execution dates and prices, though the regularity of the transaction structure indicates predetermined parameters governed Begor's stock sales.

Begor Receives Stock Option Grant at $112.46 Exercise Price

Concurrent with his stock sales, Begor received a grant of 37,791 stock options, the same number of shares he sold on July 24, 2026. The options carry an exercise price of $112.46 per share, which the filing indicates was the price point referenced for the option grant mechanism. These options are exercisable beginning May 4, 2028, and expire on the same date, providing a two-year window for exercise following the vesting schedule.

The filing discloses that the stock options vested in three equal annual increments beginning May 4, 2019, according to a standard vesting schedule notation in the explanatory notes. The grant of options alongside the sale of common stock is consistent with equity compensation practices at large publicly-traded companies, where executives receive periodic grants of equity incentives as part of their overall compensation package. The timing and quantity alignment between shares sold and options granted suggest a coordinated equity transaction structure.

Direct and Indirect Beneficial Ownership Holdings Following Transaction

Following all reported transactions on July 24, 2026, Begor's direct beneficial ownership of Equifax common stock totaled 271,890 shares. This figure represents his holdings in the form of direct ownership, distinct from any indirect ownership interests. The filing indicates that the beneficial ownership calculation includes accrued dividend equivalent units representing dividends that were reinvested in corresponding restricted stock units through the company's last dividend payment date, as well as 226 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.

In addition to his direct common stock holdings, Begor maintains indirect beneficial ownership of common stock through several grantor retained annuity trusts (GRATs). The filing reports indirect beneficial ownership of 2,350 shares through a two-year GRAT established in April 2025, 21,284 shares through a two-year GRAT established in December 2025, 38,332 shares through a two-year GRAT established in June 2025, 2,018 shares through a two-year GRAT established in May 2025, and 18,562 shares through a two-year GRAT established in May 2026. These indirect holdings through trust structures are commonly used by high-net-worth individuals for estate planning and wealth management purposes.

Stock Price Ranges and Execution Details Across Multiple Transaction Blocks

The filing provides detailed information regarding the price ranges at which Begor's shares were sold across the ten transaction blocks reported on July 24, 2026. For the first major sale block of 500 shares with a weighted average price of $175.85, the actual execution prices ranged from $175.74 to $175.94. The second block of 600 shares with a weighted average price of $169.86 saw execution prices ranging from $169.42 to $170.09. These price ranges reflect the natural price movement that occurred during the trading day as the transactions were executed.

Subsequent sale blocks show similar patterns of price variation during execution. The third block of 600 shares executed at a weighted average of $168.47, with prices ranging from $168.40 to $168.55. The fourth block of 1,300 shares had a weighted average of $174.91, with prices ranging from $174.54 to $175.48. The largest single transaction block involved 21,543 shares at a weighted average price of $171.99, with prices ranging from $171.50 to $172.49. These granular details demonstrate the diversity of execution prices experienced during what appears to be a systematic liquidation of equity holdings throughout a single trading session.

Option Grant Terms and Expiration Timeline

The stock option grant received by Begor specifies an exercise price of $112.46 per share, which serves as the price at which Begor may purchase common stock if he chooses to exercise the options. The options become exercisable on May 4, 2028, and expire on that same date, creating a two-year exercise window. This expiration timeline is relatively short compared to some equity grant structures, suggesting that the options may represent a specific tranche of compensation or a one-time equity award rather than ongoing annual equity grants.

The vesting history notation in the filing indicates that the option grant vested in three equal annual increments beginning May 4, 2019. This information appears to reference historical vesting details rather than prospective vesting schedules, suggesting that the options reported in this transaction may have already satisfied their vesting requirements or may be subject to different vesting terms not explicitly detailed in the filing. The total number of derivative securities beneficially owned following the transaction is reported as 37,792 options, reflecting the newly granted options in Begor's portfolio.

Employee Stock Purchase Plan Participation and Dividend Reinvestment

The filing notes that Begor's beneficial ownership calculation includes 226 shares of common stock acquired pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Employee stock purchase plans (ESPPs) are programs that allow eligible employees, including executives, to purchase company stock at a discount through payroll deductions. The inclusion of these 226 shares in Begor's beneficial ownership demonstrates his participation in this equity program in addition to his option grants and direct stock holdings.

Additionally, the filing indicates that Begor's beneficial ownership includes accrued dividend equivalent units representing dividends that were reinvested in corresponding restricted stock units through the company's last dividend payment date. This notation suggests that Begor's restricted stock units are structured to provide dividend reinvestment mechanisms, allowing dividend payments on restricted stock to be automatically converted into additional shares or units. Such reinvestment features are common in executive compensation structures and can result in a gradual increase in holdings over time as dividend distributions are capitalized into additional equity.

GRAT Holdings and Indirect Beneficial Ownership Structure

Begor maintains significant indirect beneficial ownership of Equifax common stock through five grantor retained annuity trusts established between April 2025 and May 2026. A GRAT is an irrevocable trust that provides a stream of annuity payments to the grantor during the trust term, with any remaining assets passing to designated beneficiaries at the conclusion of the trust period. The filing reports GRAT-based holdings totaling 82,546 shares across five separate trusts with varying establishment dates and share quantities.

The April 2025 two-year GRAT holds 2,350 shares, while the December 2025 two-year GRAT holds the largest portion with 21,284 shares. The June 2025 two-year GRAT contains 38,332 shares, making it the largest single GRAT holding reported. The May 2025 two-year GRAT holds 2,018 shares, and the most recent May 2026 two-year GRAT holds 18,562 shares. The staggered establishment dates and two-year terms suggest a deliberate estate planning strategy that spreads beneficial transfer events across multiple time periods, potentially for tax efficiency and risk management purposes.

Executive Role and Reporting Obligations

Mark W. Begor is identified in the filing as both a Director and Officer of Equifax Inc., with his specific officer title listed as CEO. As a senior executive and director, Begor is subject to Section 16 reporting obligations under the Securities Exchange Act of 1934, requiring disclosure of beneficial ownership changes within two trading days of transaction execution. The filing was executed on July 28, 2026, which represents the standard two-business-day reporting period following the July 24, 2026 transaction date.

The form was signed by Lisa Stockard as attorney-in-fact on behalf of Begor, indicating that authorized representatives may execute the required SEC disclosures on behalf of the reporting person. The residence address listed for Begor is 1550 Peachtree Street, N.W., in Atlanta, Georgia, which corresponds to Equifax's headquarters location. This address alignment is common for executives whose personal residences may be in close proximity to corporate headquarters or who may use a corporate address for regulatory filing purposes.

Timing and Context of Mid-Summer Equity Transaction

The July 24, 2026 transaction date falls within the summer trading period, when many corporate executives conduct equity management activities. The pre-established Rule 10b5-1 trading plan adopted in October 2025 provided the legal framework for executing these transactions during this timeframe. The filing provides no information regarding the company's financial performance, business developments, or market conditions surrounding the transaction, as such contextual information is not required to be disclosed in insider trading reports.

The immediate share price impact was not clear from available public information. The filing documents the transaction prices at which Begor's shares were sold and the terms under which his option grant was issued, but does not address broader market impacts or the reasons underlying Begor's equity management decisions on this particular date. The disclosure serves primarily as a regulatory record of the transaction mechanics and beneficial ownership positions rather than as a commentary on market conditions or corporate strategy.